AMR Action Fund
John Alter, the Interim Head of External Affairs, was previously Vice President of Patient and Health Impact for Pfizer’s Hospital business unit, which has worldwide sales of more than $8B from a portfolio of over 170 molecules (including 50 medicines on the World Health Organization’s Essential Medicines List) and ten drug delivery systems. Pfizer’s Patient and Health Impact team covers the functions of Pricing, Access, Reimbursement, Health Economics, Outcomes Research, and Real-World Data. John has been with Pfizer for 22 years in multiple roles of increasing responsibilities.
John holds a BS from Villanova University and an MBA from George Mason University.
This person is not in any offices
AMR Action Fund
The AMR Action Fund is a ground-breaking collective venture launched by more than 20 leading pharmaceutical companies to bring 2 to 4 new antibiotics to patients by the end of the decade.